Home Home Home Inbox Home Search

Event

Safety and Efficacy of SAR156597 in Idiopathic Pulmonary Fibrosis (IPF): A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

Location: 6A
Session Type: Mini Symposium
Sunday
May
20
4:00 PM
4:15 PM

Speaker(s)/Author(s)

Bruno Crestani

MD, PhD
Hopital Bichat;HOPITAL BICHAT CLAUDE BERNARD;Hopital Bichat-Claude Bernard, APHP

Luca Richeldi

MD, PhD
Catholic University of the Sacred Heart;Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli

Christina Soubrane

MD
Sanofi R&D

Raphael Bejuit

PhD
Sanofi R&D

Peter Wung

MD
Sanofi R&D

Ganesh Raghu

MD
Univ of Washington Medical Ctr

Corinne Esperet

PhD
Sanofi R&D

View Abstract

Safety and Efficacy of SAR156597 in Idiopathic Pulmonary Fibrosis (IPF): A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

Parent Sessions

  • A93 - ILD: CLINICAL TRIALS
    05-20-2018 2:15 PM - 4:15 PM
    • Home Home Home Inbox Home Search